Determination of N-acetylcysteine in human plasma by liquid chromatography coupled to tandem mass spectrometry

被引:31
作者
Celma, C [1 ]
Allué, JA [1 ]
Pruñonosa, J [1 ]
Peraire, C [1 ]
Obach, R [1 ]
机构
[1] Ipsen Pharma, Dept Metab & Pharmacokinet, St Feliu De Llobregat 08980, Barcelona, Spain
关键词
validation; acetylcysteine; amino acids; acetylserine;
D O I
10.1016/S0021-9673(99)01078-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An analytical method for the determination of total N-acetylcysteine in human plasma has been developed, validated and applied to the analysis of samples from a phase I clinical trial. The analytical method consists of plasma digestion with dithiothreitol in order to reduce all the oxidized forms of N-acetylcysteine, and extraction with ethyl acetate followed by determination of levels by an LC-MS-MS method. The intra- and inter-assay precision and accuracy of this technique were good and the limit of quantitation was 50 ng/ml of plasma. The concentration working range was established between 50 ng/ml and 1000 ng/ml. This method has been used in the analysis of approximately 800 human plasma samples from a clinical study with 24 volunteers; the precision of the quality controls was in the range 8.7 to 13.4% and the accuracy was in the range -5.9 to 8.5%, expressed as the RSD and the relative error, respectively. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:13 / 22
页数:10
相关论文
共 13 条
[1]  
Borman G., 1983, EUR J RESPIR DIS, V61, P405
[2]   High-performance liquid chromatography assay for N-acetylcysteine in biological samples following derivatization with N-(1-pyrenyl)maleimide [J].
Ercal, N ;
Oztezcan, S ;
Hammond, TC ;
Matthews, RH ;
Spitz, DR .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 685 (02) :329-334
[3]   Total N-acetylcysteine levels are elevated in the plasma of patients with chronic renal failure [J].
Fisher, DH ;
Bostom, AG .
ANALYTICAL LETTERS, 1997, 30 (10) :1823-1831
[4]   ENDOGENOUS PLASMA N-ACETYLCYSTEINE AND SINGLE DOSE ORAL BIOAVAILABILITY FROM 2 DIFFERENT FORMULATIONS AS DETERMINED BY A NEW ANALYTICAL METHOD [J].
GABARD, B ;
MASCHER, H .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1991, 12 (05) :343-353
[5]   CONTROLLED TRIAL OF INTERMITTENT ORAL ACETYLCYSTEINE IN LONG-TERM TREATMENT OF CHRONIC-BRONCHITIS [J].
GRASSI, C ;
MORANDINI, GC .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 9 (5-6) :393-396
[6]   DETERMINATION OF 3-MERCAPTOLACTATE, MERCAPTOACETATE AND N-ACETYLCYSTEINE IN URINE BY GAS-CHROMATOGRAPHY [J].
HANNESTAD, U ;
SORBO, B .
CLINICA CHIMICA ACTA, 1979, 95 (02) :189-200
[7]   CLINICAL PHARMACOKINETICS OF N-ACETYLCYSTEINE [J].
HOLDINESS, MR .
CLINICAL PHARMACOKINETICS, 1991, 20 (02) :123-134
[8]   DETERMINATION OF N-ACETYLCYSTEINE IN HUMAN PLASMA BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
LONGO, A ;
DITORO, M ;
GALIMBERTI, C ;
CARENZI, A .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 562 (1-2) :639-645
[9]  
MORGAN RL, 1983, SEMINARS ONCOL, V10, P56
[10]   INTRAVENOUS N-ACETYLCYSTEINE - TREATMENT OF CHOICE FOR PARACETAMOL POISONING [J].
PRESCOTT, LF ;
ILLINGWORTH, RN ;
CRITCHLEY, JAJH ;
STEWART, MJ ;
ADAM, RD ;
PROUDFOOT, AT .
BRITISH MEDICAL JOURNAL, 1979, 2 (6198) :1097-1100